In terms of FOXM1 and TRIP13, they have been well documented for their oncogenic roles in HCC, and FOXM1 and TRIP13 high expression was associated with the poor prognosis of HCC patients [25, 26]. Here, FOXM1 is linked to hepatocellular carcinoma.